Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.
Standard
Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia. / Luetkens, Tim; Schafhausen, Philippe; Uhlich, Frederike; Stasche, Tim; Akbulak, Ruken Özge; Bartels, Britta M; Hildebrandt, York; Gontarewicz, Artur; Kobold, Sebastian; Meyer, Sabrina; Gordic, Maja; Bartels, Katrin; Lajmi, Nesrine; Cao, Yanran; Kröger, Nicolaus; Bokemeyer, Carsten; Brümmendorf, Tim; Atanackovic, Djordje.
in: LEUKEMIA RES, Jahrgang 34, Nr. 12, 12, 2010, S. 1647-1655.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.
AU - Luetkens, Tim
AU - Schafhausen, Philippe
AU - Uhlich, Frederike
AU - Stasche, Tim
AU - Akbulak, Ruken Özge
AU - Bartels, Britta M
AU - Hildebrandt, York
AU - Gontarewicz, Artur
AU - Kobold, Sebastian
AU - Meyer, Sabrina
AU - Gordic, Maja
AU - Bartels, Katrin
AU - Lajmi, Nesrine
AU - Cao, Yanran
AU - Kröger, Nicolaus
AU - Bokemeyer, Carsten
AU - Brümmendorf, Tim
AU - Atanackovic, Djordje
PY - 2010
Y1 - 2010
N2 - Cancer-testis (CT) antigens represent attractive targets for tumor immunotherapy based on their tumor-restricted expression and immunogenicity. However, a broad picture of the expression of CT antigens and associated humoral immune responses in chronic myeloid leukemia (CML) is still missing.
AB - Cancer-testis (CT) antigens represent attractive targets for tumor immunotherapy based on their tumor-restricted expression and immunogenicity. However, a broad picture of the expression of CT antigens and associated humoral immune responses in chronic myeloid leukemia (CML) is still missing.
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Disease-Free Survival
KW - derivatives
KW - Antigens, Neoplasm biosynthesis
KW - Antimetabolites, Antineoplastic pharmacology
KW - Azacitidine analogs
KW - Drug Resistance, Neoplasm drug effects
KW - Epigenesis, Genetic drug effects
KW - Gene Expression Regulation, Leukemic drug effects
KW - Immunity, Humoral drug effects
KW - Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
KW - Neoplasm, Residual immunology
KW - Piperazines therapeutic use
KW - Pyrimidines therapeutic use
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Disease-Free Survival
KW - derivatives
KW - Antigens, Neoplasm biosynthesis
KW - Antimetabolites, Antineoplastic pharmacology
KW - Azacitidine analogs
KW - Drug Resistance, Neoplasm drug effects
KW - Epigenesis, Genetic drug effects
KW - Gene Expression Regulation, Leukemic drug effects
KW - Immunity, Humoral drug effects
KW - Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
KW - Neoplasm, Residual immunology
KW - Piperazines therapeutic use
KW - Pyrimidines therapeutic use
M3 - SCORING: Zeitschriftenaufsatz
VL - 34
SP - 1647
EP - 1655
JO - LEUKEMIA RES
JF - LEUKEMIA RES
SN - 0145-2126
IS - 12
M1 - 12
ER -